President and COOCIK 0001780664
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Rubinstein JuliePresident and COO |  ADPTAdaptive Biotechnologies CorpOpen-market sale · 10b5-1 plan | SELL | $332K 11.7K sh | Oct 29, 2026 traded Oct 28, 2026 | |
Rubinstein JuliePresident and COO |
| ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan |
| M |
| $144K 11.9K sh |
| Oct 29, 2026 traded Oct 28, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $244K 8,881 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 29, 2026 traded Oct 27, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 29, 2026 traded Oct 28, 2026 |
| 4 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $336K 11.9K sh | Oct 29, 2026 traded Oct 29, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $80K 3,000 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 29, 2026 traded Oct 29, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 29, 2026 traded Oct 29, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 29, 2026 traded Oct 27, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $5,780 200 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 26, 2026 traded Oct 23, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 26, 2026 traded Oct 26, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $187K 7,381 sh | Oct 26, 2026 traded Oct 23, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $248K 10.2K sh | Oct 26, 2026 traded Oct 22, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $110K 4,500 sh | Oct 26, 2026 traded Oct 23, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 26, 2026 traded Oct 26, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $43K 1,700 sh | Oct 26, 2026 traded Oct 22, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $221K 8,503 sh | Oct 26, 2026 traded Oct 26, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 26, 2026 traded Oct 22, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 26, 2026 traded Oct 23, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $89K 3,378 sh | Oct 26, 2026 traded Oct 26, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 26, 2026 traded Oct 22, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $150K 5,882 sh | Oct 21, 2026 traded Oct 21, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 21, 2026 traded Oct 20, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 21, 2026 traded Oct 21, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 21, 2026 traded Oct 21, 2026 |
| 3 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $2,485 100 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $151K 5,999 sh | Oct 21, 2026 traded Oct 21, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 21, 2026 traded Oct 20, 2026 |
| 9 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $286K 11.9K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 9 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $289K 11.8K sh | Oct 21, 2026 traded Oct 20, 2026 |
| 3 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $7,635 300 sh | Oct 16, 2026 traded Oct 16, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 16, 2026 traded Oct 14, 2026 |
| 6 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $132K 5,100 sh | Oct 16, 2026 traded Oct 14, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 16, 2026 traded Oct 15, 2026 |
| 9 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $304K 11.9K sh | Oct 16, 2026 traded Oct 15, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 16, 2026 traded Oct 16, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 16, 2026 traded Oct 14, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 16, 2026 traded Oct 15, 2026 |
| 9 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $280K 11.6K sh | Oct 16, 2026 traded Oct 16, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 16, 2026 traded Oct 16, 2026 |
| 6 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $173K 6,781 sh | Oct 16, 2026 traded Oct 14, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 13, 2026 traded Oct 13, 2026 |
| 9 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $314K 11.9K sh | Oct 13, 2026 traded Oct 9, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 13, 2026 traded Oct 12, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 13, 2026 traded Oct 9, 2026 |
| 6 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $233K 9,181 sh | Oct 13, 2026 traded Oct 12, 2026 |
| 6 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $70K 2,700 sh | Oct 13, 2026 traded Oct 12, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 13, 2026 traded Oct 13, 2026 |
| 9 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $303K 11.9K sh | Oct 13, 2026 traded Oct 13, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 13, 2026 traded Oct 9, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 13, 2026 traded Oct 12, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 8, 2026 traded Oct 7, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 8, 2026 traded Oct 6, 2026 |
| 9 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $314K 11.9K sh | Oct 8, 2026 traded Oct 7, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 8, 2026 traded Oct 8, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 8, 2026 traded Oct 6, 2026 |